日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Case-Based Immunology: B Cells and Systemic Sclerosis Interstitial Lung Disease

基于病例的免疫学:B细胞与系统性硬化症间质性肺病

Goldman, Nina; Ong, Voon; Denton, Christopher P

Distinct Effects of Complement C4A and C4B Copy Numbers in Systemic Sclerosis Serological and Clinical Subtypes

补体C4A和C4B拷贝数在系统性硬化症血清学和临床亚型中的不同作用

Martínez-López, Javier; Rangel-Peláez, Carlos; Rodriguez-Martin, Inmaculada; Guillen-Del-Castillo, Alfredo; Simeón-Aznar, Carmen P; Callejas, José L; Distler, Oliver; Proudman, Susanna M; Nikpour, Mandana; Hunzelmann, Nicolas; Moroncini, Gianluca; de Vries-Bouwstra, Jeska K; Herrick, Ariane L; Allanore, Yannick; Alarcon-Riquelme, Marta E; Beretta, Lorenzo; Assassi, Shervin; Denton, Christopher P; Mayes, Maureen D; Martin, Javier; Acosta-Herrera, Marialbert; Kerick, Martin

A randomised open-label pilot trial comparing mycophenolate mofetil with no immunosuppression in limited cutaneous systemic sclerosis (MINIMISE-Pilot)

一项随机开放标签试点试验比较了霉酚酸酯与不进行免疫抑制治疗在局限性皮肤系统性硬化症中的疗效(MINIMISE-Pilot)

Denton, Christopher P; Yee, Philip; Kanitkar, Medha; Sims, Hannah; Clarke, Charlotte; Ahmed, Saiam; Ong, Voon H; Del Galdo, Francesco; Pauling, John D; Anderson, Marina E; Samaranayaka, Muditha; Hughes, Michael; Bhat, Smita; Griffiths, Bridget; Buch, Maya H; Herrick, Ariane L; D'Cruz, David; Vonk, Madelon C; Freemantle, Nick; Dehbi, Hakim-Moulay

Impact of hand function impairment on daily life of patients with systemic sclerosis: a qualitative study

手功能障碍对系统性硬化症患者日常生活的影响:一项定性研究

Greveling, Mark; Rodolfi, Stefano; El Bardai, Nora; Denton, Christopher P; Ong, Voon H; Jeffries-Owen, Nick; Schriemer, Rita; Tweehuysen, Lieke; Spierings, Julia

Advancing drug development for systemic sclerosis by prioritizing findings from human genetic association studies

通过优先考虑人类遗传关联研究的发现,推进系统性硬化症药物的研发

Hughes, Michael; McMahan, Zsuzsanna H; Assassai, Shervin; Denton, Christopher P; Providencia, Rui

Suppression of premature ventricular complexes with the PDE5 inhibitor sildenafil: First clinical experience

使用PDE5抑制剂西地那非抑制室性早搏:首例临床经验

Hutchings, David C; Denton, Christopher P; Venetucci, Luigi; Trafford, Andrew W

Lymphocyte Activation Gene 3 Regulation of Profibrotic Cytokines and Type I Collagen Production in Patients With Systemic Sclerosis.

淋巴细胞活化基因 3 对系统性硬化症患者促纤维化细胞因子和 I 型胶原蛋白生成的调控。

Aspari Maithri, Greisen Stinne, Hvid Malene, Ong Voon H, Denton Christopher P, Abraham David, Deleuran Bent

Serum Type I Interferon Score for Prediction of Clinically Meaningful Disease Progression in Limited Cutaneous Systemic Sclerosis

血清I型干扰素评分预测局限性皮肤系统性硬化症的临床意义疾病进展

Di Donato, Stefano; Ross, Rebecca; Karanth, Ranjitha; Kakkar, Vishal; De Lorenzis, Enrico; Bissell, Lesley-Anne; Clark, Kristina; Yee, Philip; Denton, Christopher P; Del Galdo, Francesco

Peripheral Blood Gene Expression Profiling and Prognostic Significance for the Course of Interstitial Lung Disease in Patients With Systemic Sclerosis

外周血基因表达谱及其对系统性硬化症患者间质性肺病病程的预后意义

Assassi, Shervin; Denton, Christopher P; Zwick, Matthias; Schmid, Ramona; Ittrich, Carina; Litzenburger, Tobias; Visvanathan, Sudha

Critical Role for Transglutaminase 2 in Scleroderma Skin Fibrosis and in the Development of Dermal Sclerosis in a Mouse Model of Scleroderma.

转谷氨酰胺酶 2 在硬皮病皮肤纤维化和硬皮病小鼠模型真皮硬化发展中的关键作用

Tam Angela Y Y, Khan Korsa, Xu Shiwen, Bergin Marianne, Huang Linghong, Colon Erik Arroyo, Cheng Danyi, Verderio Elisabetta A M, Ong Voon, Denton Christopher P, Atkinson John, Johnson Tim S, Abraham David J